Warren Stone insider trades

Open-market stock purchases and sales by Warren Stone, Pres & Chief Operating Officer at Neogenomics Inc, from SEC Form 4 filings since Dec 1, 2022.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +93%.

Recent trades

DateStockTradeValue
May 11, 2026NEO Neogenomics IncSold (not open market)—
May 11, 2026NEO Neogenomics IncBought (not open market)—
May 2, 2026NEO Neogenomics IncSold (not open market)—
May 2, 2026NEO Neogenomics IncBought (not open market)—
Apr 1, 2026NEO Neogenomics IncSold (not open market)—
Apr 1, 2026NEO Neogenomics IncBought (not open market)—
Mar 1, 2026NEO Neogenomics IncBought (not open market)—
Mar 1, 2026NEO Neogenomics IncBought (not open market)—
Feb 23, 2026NEO Neogenomics IncSold (not open market)—
Feb 23, 2026NEO Neogenomics IncBought (not open market)—
Feb 21, 2026NEO Neogenomics IncSold (not open market)—
Feb 21, 2026NEO Neogenomics IncBought (not open market)—
Jan 20, 2026NEO Neogenomics IncSold$277K
Jan 13, 2026NEO Neogenomics IncBought (not open market)—
Jan 13, 2026NEO Neogenomics IncSold (not open market)—
Dec 1, 2025NEO Neogenomics IncSold (not open market)—

Companies traded

  • NEO Neogenomics Inc: 1 buy, 1 sale, last May 11, 2026

Get free alerts when Warren Stone files a new trade →